ATE43244T1 - Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung. - Google Patents

Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung.

Info

Publication number
ATE43244T1
ATE43244T1 AT86107343T AT86107343T ATE43244T1 AT E43244 T1 ATE43244 T1 AT E43244T1 AT 86107343 T AT86107343 T AT 86107343T AT 86107343 T AT86107343 T AT 86107343T AT E43244 T1 ATE43244 T1 AT E43244T1
Authority
AT
Austria
Prior art keywords
dermic
pharmaceutical composition
ophthalmic use
ointment form
active ingredient
Prior art date
Application number
AT86107343T
Other languages
English (en)
Inventor
Annibale Gazzaniga
Federico Stroppolo
Valter Gianesello
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE43244T1 publication Critical patent/ATE43244T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT86107343T 1985-05-30 1986-05-30 Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung. ATE43244T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20970/85A IT1190361B (it) 1985-05-30 1985-05-30 Composizione farmaceutica in crema per uso dermale ed oftalmico
EP86107343A EP0205051B1 (de) 1985-05-30 1986-05-30 Pharmazeutische Zusammensetzung in Form einer Salbe zur dermischen und ophthalmischen Verwendung

Publications (1)

Publication Number Publication Date
ATE43244T1 true ATE43244T1 (de) 1989-06-15

Family

ID=11174785

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86107343T ATE43244T1 (de) 1985-05-30 1986-05-30 Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung.

Country Status (5)

Country Link
EP (1) EP0205051B1 (de)
JP (1) JPH0764745B2 (de)
AT (1) ATE43244T1 (de)
DE (1) DE3663449D1 (de)
IT (1) IT1190361B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE74009T1 (de) * 1986-08-11 1992-04-15 American Cyanamid Co Zusammensetzungen zur parenteralen verabreichung und deren verwendung.
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
WO1989001489A1 (en) * 1987-08-10 1989-02-23 Commonwealth Scientific And Industrial Research Or Control of angiogenesis and compositions and methods therefor
US5705485A (en) * 1987-09-18 1998-01-06 Ethicon, Inc. Gel formulations containing growth factors
US5032575A (en) * 1988-10-12 1991-07-16 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
US5051443A (en) * 1988-10-12 1991-09-24 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
US5036046A (en) * 1988-10-12 1991-07-30 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
JPH04305528A (ja) * 1991-02-22 1992-10-28 Dai Ichi Seiyaku Co Ltd ケラチノサイト及び皮膚線維芽細胞の増殖刺激剤
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
US5290920A (en) * 1992-04-16 1994-03-01 Allelix Biopharmaceuticals Inc. Method of purifying human epidermal growth factor
FR2695557A1 (fr) * 1992-09-15 1994-03-18 Rochas Sa Parfums Composition biologique contenant des EGF destinée à réguler la croissance cellulaire.
FR2695556B1 (fr) * 1992-09-15 1995-03-24 Rochas Sa Parfums Composition biologique contenant des EGF destinée à réguler la croissance cellulaire.
KR100366439B1 (ko) * 2000-02-21 2003-01-09 주식회사 대웅 상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물
KR102114993B1 (ko) * 2015-10-15 2020-05-25 주식회사 파이안에스테틱스 폴리펩타이드 및/또는 세포 배양 여액을 함유하는 수용성 스크럽 입자를 포함하는 화장제 조성물
CN110652493A (zh) * 2019-10-31 2020-01-07 福建蓝昊肽生物科技发展有限公司 一种增加生物活性肽乳膏稳定性的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0140998B1 (de) * 1983-11-02 1989-11-15 Nihon Chemical Research Kabushiki Kaisha Augenpräparate
JPS615006A (ja) * 1984-06-19 1986-01-10 Sanki Shoji Kk 皮膚用剤

Also Published As

Publication number Publication date
JPS6227A (ja) 1987-01-06
DE3663449D1 (en) 1989-06-29
JPH0764745B2 (ja) 1995-07-12
EP0205051A1 (de) 1986-12-17
IT8520970A0 (it) 1985-05-30
EP0205051B1 (de) 1989-05-24
IT1190361B (it) 1988-02-16

Similar Documents

Publication Publication Date Title
ATE43244T1 (de) Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung.
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ZA885192B (en) Pharmaceutical preparations
NO170194C (no) Fremgangsmaate for fremstilling av fysiologisk aktive saarhelingsstoffer
DE3875425D1 (de) Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.
DE3772139D1 (de) Kosmetische zusammensetzung.
ATE122885T1 (de) Mittel zur behandlung von herzerkrankungen.
DE69332350D1 (de) Verwendung von Lycopen zur Verminderung der Zellaktivität, insbesondere von Krebszellen, sowie entsprechende pharmazeutische Zubereitungen
DE69535081D1 (de) Verwendung von Prostaglandin A oder dessen Derivaten zur Behandlung von Psoriasis
ATE206914T1 (de) Verwendung von ursolsäure zur herstellung eines arzneimittels zur unterdrückung von metastasen
ATE107168T1 (de) Verwendung von gepiron zur herstellung eines pharmazeutischen präparats zur behandlung atypischer depression.
IT1240683B (it) Composizione farmaceutica contenente egf
SE8703210L (sv) Hudvardskompositioner med keratolytisk och antiinflammatorisk aktivitet
DE3685275D1 (de) Herstellung von 5-fluor-2'-deoxyuridin estern zur intravenoesen verabreichung.
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
FR2616325B1 (fr) Composition contenant de l'hydroquinone et de l'acide kojique et composition pharmaceutique, notamment dermatologique, a activite depigmentante ou anti-inflammatoire, ou cosmetique comprenant de l'acide kojique et de l'hydroquinone
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
NO892495D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparat.
ATE66375T1 (de) Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung.
SE8705035L (sv) Anvaendning av alkylglycerol
FR2392674A1 (fr) Compositions pharmaceutiques a base d'elastine
IT8520514A0 (it) Composizioni di farmaci dotate di attivita' antimicrobica eprocedimento per la loro preparazione.
DE3665403D1 (en) Pharmaceutical composition for topical application
ATE56360T1 (de) Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma.
ATE53384T1 (de) 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee